cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Exact Sciences Corporation
88 own
24 watching
Current Price
$65.04
$0.79
(1.23%)
logo-exas
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
11,528.57M
52-Week High
52-Week High
84.31
52-Week Low
52-Week Low
29.27
Average Volume
Average Volume
1.76M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization11,528.57M
icon52-Week High84.31
icon52-Week Low29.27
iconAverage Volume1.76M
iconDividend Yield--
iconP/E Ratio--
What does the Exact Sciences Corporation do?
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Read More
How much money does Exact Sciences Corporation make?
News & Events about Exact Sciences Corporation.
Invezz News
3hours ago
Cathie Wood seems to be having a fantastic start to the new year with her ARK Innovation ETF now up 25% year-to-date and shes continuing to make adjustments to her holdings in hopes of even better returns moving forward. Cathie Wood sells more of EXAS The billionaire investor ...
PR Newswire
6days ago
Thinking about trading options or stock in Microsoft, Tesla, Roku, Alphabet, or Exact Sciences? Thinking about trading options or stock in Microsoft, Tesla, Roku, Alphabet, or Exact Sciences? PR Newswire NEW YORK, Jan. 20, 2023 NEW YORK, Jan. 20, 2023 /PRNewswire/ --InvestorsObserverissues critical...
Ticker Report
14days ago
Exact Sciences (NASDAQ:EXAS Get Rating) had its price objective upped by Craig Hallum from $35.00 to $44.00 in a research note issued to investors on Monday morning, The Fly reports. A number of other equities analysts have also recently commented on the stock. Piper Sandler lifted their ...
TheStreet.com
16days ago
The asset manager bought shares of the graphics-software specialist and the electric-vehicle leader as both stocks have dropped.The asset manager bought shares of the graphics-software specialist and the electric-vehicle leader as both stocks have dropped.The prominent asset manager Cathie Wood, ...
PR Newswire
17days ago
Thinking about trading options or stock in Exact Sciences, Futu Holdings, Tesla, Five Below, or NVIDIA? Thinking about trading options or stock in Exact Sciences, Futu Holdings, Tesla, Five Below, or NVIDIA? PR Newswire NEW YORK, Jan. 9, 2023 NEW YORK, Jan. 9, 2023 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Exact Sciences Corporation share price today?
plus_minus_icon
Can Indians buy Exact Sciences Corporation shares?
plus_minus_icon
How can I buy Exact Sciences Corporation shares from India?
plus_minus_icon
Can Fractional shares of Exact Sciences Corporation be purchased?
plus_minus_icon
What are the documents required to start investing in Exact Sciences Corporation stocks?
plus_minus_icon
What is today’s traded volume of Exact Sciences Corporation?
plus_minus_icon
What is today’s market capitalisation of Exact Sciences Corporation?
plus_minus_icon
What is the 52-Week High and Low Range of Exact Sciences Corporation?
plus_minus_icon
What percentage is Exact Sciences Corporation down from its 52-Week High?
plus_minus_icon
What percentage is Exact Sciences Corporation up from its 52-Week Low?
plus_minus_icon
Current Price
$65.04
$0.79
(1.23%)
logo-exas
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NovoCure Limited
NovoCure Limited
$90.05
$-0.11 (-0.12 %)
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
$475.91
$19.22 (4.21 %)
Insulet Corporation
Insulet Corporation
$286.13
$-3.57 (-1.23 %)
Myriad Genetics Inc.
Myriad Genetics Inc.
$19.81
$-0.70 (-3.41 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
NovoCure Limited
NovoCure Limited
$90.05
$-0.11 (-0.12 %)
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
$475.91
$19.22 (4.21 %)
Insulet Corporation
Insulet Corporation
$286.13
$-3.57 (-1.23 %)
Myriad Genetics Inc.
Myriad Genetics Inc.
$19.81
$-0.70 (-3.41 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00